Related Experiment Video
Updated: Mar 22, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS
Lia Furlaneto Marega1, Marcelo Ananias Teocchi1, Maria Marluce Dos Santos Vilela1
1Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, Faculty of Medical Sciences, University of Campinas - UNICAMP, Campinas, SP, Brazil.
Abstract:
Most cases of autoimmune lymphoproliferative syndrome (ALPS) have an inherited genetic defect involving apoptosis-related genes of the FAS pathway. MicroRNAs (miRNAs) are a class of small non-coding regulatory RNAs playing a role in the control of gene expression. This is the first report on miRNAs in ALPS patients. We studied a mother and son carrying the same FAS cell surface death receptor (FAS) mutation, but with only the son manifesting the signs and symptoms of ALPS-FAS. The aim was to analyse, by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), the peripheral blood mononuclear cells (PBMC) relative expression of miR-146a and miR-21, including their passenger strands and respective targets (FAS and FASLG). In comparison with healthy matched control individuals, miR-21-3p was over-expressed significantly (P = 0·0313) in the son, with no significant change in the expression of miR-146a, miR-146a-3p and miR-21. In contrast, the mother had a slight under-expression of the miR-146a pair and miR-21-3p (P = 0·0625). Regarding the miRNA targets, FAS was up-regulated markedly for the mother (P = 0·0078), but down-regulated for the son (P = 0·0625), while FASLG did not have any significant alteration. Taken together, our finding clearly suggests a role of the miR-146a/FAS axis in ALPS-FAS variable expressivity in which FAS haploinsufficiency seems to be compensated only in the mother who had the miR-146a pair down-regulated. As only the son had the major clinical manifestations of ALPS-FAS, miR-21-3p should be investigated as playing a critical role in ALPS physiopathology, including the development of lymphoma.
Insights
This study reveals microRNAs (miRNAs) play a role in autoimmune lymphoproliferative syndrome (ALPS) with FAS mutations. miR-21-3p over-expression in the son correlates with ALPS-FAS, suggesting its critical role in disease development.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Autoimmune lymphoproliferative syndrome (ALPS) is often caused by inherited defects in FAS pathway apoptosis genes.
- MicroRNAs (miRNAs) are regulatory RNAs influencing gene expression, but their role in ALPS is unexplored.
Observation:
- A mother and son with the same FAS mutation showed differing ALPS-FAS severity.
- The son, exhibiting ALPS-FAS symptoms, had significantly over-expressed miR-21-3p in peripheral blood mononuclear cells (PBMCs).
- The mother, asymptomatic, showed slight under-expression of miR-146a and miR-21-3p, with up-regulated FAS expression.
Findings:
- miR-21-3p over-expression in the son suggests a critical role in ALPS-FAS pathogenesis.
- The miR-146a/FAS axis may influence ALPS-FAS variable expressivity, with potential compensation in the asymptomatic mother.
- FASLG expression remained unchanged in both individuals.
Implications:
- miR-21-3p warrants further investigation for its role in ALPS-FAS and associated lymphoma development.
- Understanding miRNA involvement could lead to novel ALPS diagnostic and therapeutic strategies.
- This research highlights the complex interplay between genetic mutations, miRNA regulation, and disease manifestation in ALPS.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway

